Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
An evaluation of cytochrome P450 isoform activities in the female dark agouti (DA) rat: relevance to its use as a model of the CYP2D6 poor metaboliser phenotype.
Biochem Pharmacol. 1994 Apr 20;47(8):1295-307. doi: 10.1016/0006-2952(94)90327-1.
Biochem Pharmacol. 1994.
PMID: 8185638
Enzymology of the reduction of the novel fused pyrazine mono-n-oxide bioreductive drug, RB90740 roles for P450 reductase and cytochrome b5 reductase.
Barham HM, Stratford IJ.
Barham HM, et al.
Biochem Pharmacol. 1996 Mar 22;51(6):829-37. doi: 10.1016/0006-2952(95)02257-0.
Biochem Pharmacol. 1996.
PMID: 8602879
Item in Clipboard
Importance of P450 reductase activity in determining sensitivity of breast tumour cells to the bioreductive drug, tirapazamine (SR 4233).
Patterson AV, Barham HM, Chinje EC, Adams GE, Harris AL, Stratford IJ.
Patterson AV, et al. Among authors: barham hm.
Br J Cancer. 1995 Nov;72(5):1144-50. doi: 10.1038/bjc.1995.478.
Br J Cancer. 1995.
PMID: 7577460
Free PMC article.
Item in Clipboard
Development and validation of a spectrophotometric assay for measuring the activity of NADH: cytochrome b5 reductase in human tumour cells.
Barham HM, Inglis R, Chinje EC, Stratford IJ.
Barham HM, et al.
Br J Cancer. 1996 Oct;74(8):1188-93. doi: 10.1038/bjc.1996.515.
Br J Cancer. 1996.
PMID: 8883403
Free PMC article.
Item in Clipboard
Cite
Cite